Error: Search field were incomplete.
This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.
Joseph A. Liberman III, Sally Berry, Larry Culpepper, Robert L. Findling, Stephen R. Marder, Del Miller, Jacobo E. Mintzer, Bruce L. Saltz, Zafar A. Sharif, and Stephen M. Stahl
Published: December 1, 2002
>Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
Stephen R. Marder, M.D., addressed the efficacy of atypical antipsychotics. In a controversial study, Geddes and collaborators1 concluded that conventional antipsychotics should be firstline treatments except when motor side effects such as EPS are a problem. However, most patients treated with conventional agents will experience some of these adverse effects.
Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.